Oxford Immunotec Global PLC (OXFD.OQ)
OXFD.OQ on NASDAQ Stock Exchange Global Market
15.76USD
1:30pm EDT
15.76USD
1:30pm EDT
Change (% chg)
$-0.11 (-0.69%)
$-0.11 (-0.69%)
Prev Close
$15.87
$15.87
Open
$15.90
$15.90
Day's High
$15.92
$15.92
Day's Low
$15.64
$15.64
Volume
6,544
6,544
Avg. Vol
34,995
34,995
52-wk High
$17.41
$17.41
52-wk Low
$10.26
$10.26
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 29.32 | -0.250 |
| Mar '18 | 21.37 | -0.401 | |
| FY 2017 | Dec '17 | 25.03 | 1.182 |
| Sep '17 | 30.43 | -0.698 | |
| Jun '17 | 26.12 | -0.735 | |
| Mar '17 | 21.50 | -0.358 | |
| FY 2016 | Dec '16 | 23.70 | -0.217 |
| Sep '16 | 26.11 | -0.179 | |
| Jun '16 | 19.15 | -0.288 | |
| Mar '16 | 17.11 | -0.316 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 5 | 33.62 | 34.00 | 33.39 | 35.09 |
| Quarter Ending Dec-18 | 5 | 29.00 | 29.40 | 28.55 | 31.54 |
| Year Ending Dec-18 | 5 | 113.15 | 113.60 | 112.82 | 122.11 |
| Year Ending Dec-19 | 5 | 127.60 | 129.54 | 125.28 | 139.55 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 5 | -0.10 | -0.09 | -0.12 | -0.15 |
| Quarter Ending Dec-18 | 5 | -0.20 | -0.16 | -0.23 | -0.21 |
| Year Ending Dec-18 | 5 | -0.96 | -0.91 | -0.98 | -0.87 |
| Year Ending Dec-19 | 5 | -0.67 | -0.58 | -0.72 | -0.53 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 47.56 | 32.45 | |
| P/E High - Last 5 Yrs. | -- | 79.01 | 47.46 | |
| P/E Low - Last 5 Yrs. | -- | 22.91 | 24.76 | |
| Beta | -0.23 | 0.86 | 0.87 | |
| Price to Sales (TTM) | 3.88 | 21.85 | 6.31 | |
| Price to Book (MRQ) | 5.63 | 5.53 | 3.81 | |
| Price to Tangible Book (MRQ) | 6.68 | 11.82 | 5.83 | |
| Price to Cash Flow (TTM) | 393.98 | 27.37 | 23.35 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.67 | 1.73 | |
| Dividend Yield - 5 Year Avg | -- | 0.68 | 1.45 | |
| Dividend 5 Year Growth Rate | -- | 5.21 | -5.47 | |
| Payout Ratio(TTM) | -- | 23.69 | 46.56 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 12.24 | 9.35 | 8.47 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 8.93 | 9.44 | 6.75 | |
| Sales - 5 Yr. Growth Rate | 37.88 | 5.50 | 7.58 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 65.94 | 472.00 | 25.58 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 88.70 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 17.72 | 7.60 | |
| Capital Spending - 5 Yr. Growth Rate | 27.68 | 10.85 | 8.44 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 4.86 | 1.71 | 2.19 |
| Current Ratio (MRQ) | 5.39 | 2.26 | 2.96 |
| LT Debt to Equity (MRQ) | 41.19 | 31.25 | 11.41 |
| Total Debt to Equity (MRQ) | 41.32 | 42.48 | 14.25 |
| Interest Coverage (TTM) | -8.29 | 33.69 | 35.04 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 55.68 | 39.78 | 54.86 | |
| Gross Margin - 5 Yr. Avg. | 53.46 | 56.04 | 53.37 | |
| EBITD Margin (TTM) | -17.14 | -- | -- | |
| EBITD - 5 Yr. Avg | -26.59 | 12.37 | 15.90 | |
| Operating Margin (TTM) | -14.74 | -27.77 | 3.68 | |
| Operating Margin - 5 Yr. Avg. | -30.99 | 4.17 | 10.98 | |
| Pre-Tax Margin (TTM) | -18.94 | -27.88 | 3.98 | |
| Pre-Tax Margin - 5 Yr. Avg. | -33.01 | 1.88 | 11.16 | |
| Net Profit Margin (TTM) | -3.24 | -30.31 | 0.72 | |
| Net Profit Margin - 5 Yr. Avg. | -26.20 | -0.39 | 7.49 | |
| Effective Tax Rate (TTM) | -- | 24.71 | 20.36 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 27.94 | 24.27 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 232,260 | 13,048,332 | 703,739,345 | |
| Net Income/Employee (TTM) | -7,536 | 653,151 | 81,128,873 | |
| Receivable Turnover (TTM) | 5.62 | 5.25 | 5.02 | |
| Inventory Turnover (TTM) | 4.87 | 4.79 | 3.61 | |
| Asset Turnover (TTM) | 0.89 | 0.76 | 0.81 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -2.88 | 2.83 | 9.67 | |
| Return on Assets - 5 Yr. Avg. | -18.37 | 5.55 | 10.83 | |
| Return on Investment (TTM) | -3.49 | 8.31 | 12.63 | |
| Return on Investment - 5 Yr. Avg. | -21.57 | 6.91 | 13.94 | |
| Return on Equity (TTM) | -5.48 | 12.22 | 14.80 | |
| Return on Equity - 5 Yr. Avg. | -24.81 | 8.07 | 15.32 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 19.75 | 27.70 | 37.88 |
| EPS (TTM) % | 51.65 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Oxford Immunotec Global PLC
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 92.46% |
| # of Holders: | 113 |
| Total Shares Held: | 24,010,603 |
| 3 Mo. Net Change: | -191,631 |
| # New Positions: | 15 |
| # Closed Positions: | 11 |
| # Increased Positions: | 61 |
| # Reduced Positions: | 41 |
| # Net Buyers: | 20 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.